Evidence map›Paper›PMID 33724648›Full record

ArticleJournal of cellular and molecular medicine2021

INO80 participates in the pathogenesis of recurrent miscarriage by epigenetically regulating trophoblast migration and invasion.

Shu Xian, Yan Zhang, Li Wang, Fang Yao, Jinli Ding, Yanqing Wang, Xiao Yang, Fangfang Dai, Tailang Yin, Yanxiang Cheng

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. CHD8-Dependent Chromatin Licensing Sustains Trophoblast Stem Cell Transcriptional Programs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shu XianDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University, Wuhan, China.ORCID 0000-0001-8097-9623
Yan ZhangDepartment of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Li WangState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fang YaoState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jinli DingReproductive Medical Center, Renmin Hospital of Wuhan University, Wuhan, China.
Yanqing WangDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University, Wuhan, China.
Xiao YangDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.ORCID 0000-0002-5172-8267
Fangfang DaiDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University, Wuhan, China.
Tailang YinReproductive Medical Center, Renmin Hospital of Wuhan University, Wuhan, China.
Yanxiang ChengDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University, Wuhan, China.
Wuhan University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University · CN

Funding

China Medical Association Clinical Medical Research Special Fund Project 2018HX0016Key R&D Program of Hubei Province 2020BCB023the National Natural Science Foundation of China 81860276the National Natural Science Foundation of China 82071655
6 · The paper itself

Abstract

The INO80 complex, a SWI/SNF family chromatin remodeler, has regulatory effects on ESC self-renewal, somatic cell reprogramming and blastocyst development. However, the role of INO80 in regulating trophoblast cells and recurrent miscarriage (RM) remains elusive. To investigate the in vivo effects of Ino80 in embryo development, we disrupted Ino80 in C57 mice, which resulted in embryonic lethality. Silencing of Ino80 led to decreased survival capacity, migration and invasion of trophoblasts. Furthermore, RNA high-throughput sequencing (RNA-seq) revealed that Ino80 silencing closely resembled the gene expression changes in RM tissues. To investigate the mechanisms for these results, RNA-seq combined with high-throughput sequencing (ChIP-seq) was used in trophoblast cells, and it showed that Ino80 physically occupies promoter regions to affect the expression of invasion-associated genes. Last, Western blotting analyses and immunofluorescence staining revealed that the content of INO80 was reduced in RM patients compared to in healthy controls. This study indicates that INO80 has a specific regulatory effect on the viability, migration and invasion of trophoblast cells. Combined with its regulation of the expression of invasion-associated genes, it has been proposed that epigenetic regulation plays an important role in the occurrence of RM, potentially informing RM therapeutic strategies.

Indexed as

Cell MovementEpigenesis, GeneticGene Expression RegulationAbortion, HabitualAdultAnimalsApoptosisATPases Associated with Diverse Cellular ActivitiesCell ProliferationCells, CulturedDNA-Binding ProteinsFemaleHumansMiceMice, Inbred C57BLPregnancyATPases Associated with Diverse Cellular ActivitiesDNA-Binding ProteinsINO80 protein, humanINO80invasiverecurrent miscarriagetrophoblast

Identifiers

PMID33724648
PMCPMC8051727
OpenAlexW3137999585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.